Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.09 CAD | +0.43% | +2.25% | +25.67% |
04-15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
04-12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.67% | 14.39B | |
+11.51% | 307B | |
+12.19% | 153B | |
+56.54% | 125B | |
+23.06% | 83.91B | |
+12.65% | 78.37B | |
+21.66% | 63.92B | |
+14.27% | 60.48B | |
+13.16% | 50.09B | |
+32.74% | 36.71B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Barclays Adjusts Price Target on Ovintiv to $60 From $69, Maintains Overweight Rating